Salvage chemotherapy in recurrent head and neck cancer: the Institut Gustave Roussy experience

Am J Otolaryngol. 1993 Sep-Oct;14(5):301-6. doi: 10.1016/0196-0709(93)90087-n.

Authors

J P Armand¹, E Cvitkovic, G Recondo, P Wibault, G Schwaab, C Domenge, E Tellez-Bernal, D Gandia, B Luboinski, F Eschwege, et al.

Affiliation

¹ Institut Gustave Roussy, Villejuif, France.

PMID: 8238757
DOI: 10.1016/0196-0709(93)90087-n

No abstract available

MeSH terms

Aged
Antineoplastic Agents / classification
Antineoplastic Agents / therapeutic use*
Carcinoma, Squamous Cell / drug therapy*
Carcinoma, Squamous Cell / mortality
Carcinoma, Squamous Cell / pathology
Cisplatin / therapeutic use*
Female
Head and Neck Neoplasms / drug therapy*
Head and Neck Neoplasms / mortality
Head and Neck Neoplasms / pathology
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Salvage Therapy / methods*

Substances

Antineoplastic Agents
Cisplatin